Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway
Oncology Reports · 2023
DOI: 10.3892/or.2023.8563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Min Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.
- Department of Radiology, The First People's Hospital of Yunnan Province (The Affiliated Hospital of Kunming University of Science and Technology), Kunming, Yunnan 650034, P.R. China.
Zitieren
APA
Li, M., Wu, R., Zhu, D., Wang, L., Liu, S., Wang, R., Deng, C., Zhang, S., Chen, M., Lu, R., Zhu, H., Mo, M., & Luo, Z. (2023). Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway. Oncology Reports. https://doi.org/10.3892/or.2023.8563
Vancouver
Li M, Wu R, Zhu D, Wang L, Liu S, Wang R, et al. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway. Oncology Reports. 2023. doi:10.3892/or.2023.8563
BibTeX
@article{Li2023,
author = {Li, Min and Wu, Rongrong and Zhu, Dongyi and Wang, Le and Liu, Shinan and Wang, Ruolan and Deng, Chaowen and Zhang, Shenglin and Chen, Min and Lu, Ruojin and Zhu, Hongxing and Mo, Mengting and Luo, Zhuang},
title = {Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway},
journal = {Oncology Reports},
year = {2023},
doi = {10.3892/or.2023.8563}
}
EUVIMED